Marksans Pharma Limited MARKSANS.NS Stock
Marksans Pharma Limited Price Chart
Marksans Pharma Limited MARKSANS.NS Financial and Trading Overview
| Marksans Pharma Limited stock price | 157.2 INR |
| Previous Close | 86.8 INR |
| Open | 87.3 INR |
| Bid | 90.2 INR x 0 |
| Ask | 90.3 INR x 0 |
| Day's Range | 87.05 - 91.9 INR |
| 52 Week Range | 38.6 - 92.8 INR |
| Volume | 4.48M INR |
| Avg. Volume | 2.83M INR |
| Market Cap | 40.88B INR |
| Beta (5Y Monthly) | 1.193835 |
| PE Ratio (TTM) | 14.071763 |
| EPS (TTM) | 7.07 INR |
| Forward Dividend & Yield | 0.5 (0.57%) |
| Ex-Dividend Date | June 7, 2023 |
| 1y Target Est | 31 INR |
MARKSANS.NS Valuation Measures
| Enterprise Value | 33.25B INR |
| Trailing P/E | 14.071763 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.2069292 |
| Price/Book (mrq) | 2.3206153 |
| Enterprise Value/Revenue | 1.795 |
| Enterprise Value/EBITDA | 9.798 |
Trading Information
Marksans Pharma Limited Stock Price History
| Beta (5Y Monthly) | 1.193835 |
| 52-Week Change | 105.68% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 92.8 INR |
| 52 Week Low | 38.6 INR |
| 50-Day Moving Average | 79.02 INR |
| 200-Day Moving Average | 64.33 INR |
MARKSANS.NS Share Statistics
| Avg. Volume (3 month) | 2.83M INR |
| Avg. Daily Volume (10-Days) | 4.28M INR |
| Shares Outstanding | 453.16M |
| Float | 197.64M |
| Short Ratio | N/A |
| % Held by Insiders | 43.99% |
| % Held by Institutions | 13.59% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.5 |
| Trailing Annual Dividend Yield | 0.57% |
| 5 Year Average Dividend Yield | 28.99% |
| Payout Ratio | 0.039 |
| Last Split Factor | 10:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 14.32% |
| Operating Margin (ttm) | 15.52% |
| Gross Margin | 50.25% |
| EBITDA Margin | 18.32% |
Management Effectiveness
| Return on Assets (ttm) | 9.38% |
| Return on Equity (ttm) | 17.75% |
Income Statement
| Revenue (ttm) | 18.52B INR |
| Revenue Per Share (ttm) | 44.75 INR |
| Quarterly Revenue Growth (yoy) | 16.19% |
| Gross Profit (ttm) | 9.31B INR |
| EBITDA | 3.39B INR |
| Net Income Avi to Common (ttm) | 2.65B INR |
| Diluted EPS (ttm) | 6.41 |
| Quarterly Earnings Growth (yoy) | 178.90% |
Balance Sheet
| Total Cash (mrq) | 7.16B INR |
| Total Cash Per Share (mrq) | 15.94 INR |
| Total Debt (mrq) | 1.23B INR |
| Total Debt/Equity (mrq) | 6.97 INR |
| Current Ratio (mrq) | 4.913 |
| Book Value Per Share (mrq) | 38.869 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.37B INR |
| Levered Free Cash Flow (ttm) | 607.45M INR |
Profile of Marksans Pharma Limited
| Country | India |
| State | N/A |
| City | Mumbai |
| Address | Grandeur |
| ZIP | 400053 |
| Phone | 91 22 4001 2000 |
| Website | https://marksanspharma.com |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Q&A For Marksans Pharma Limited Stock
What is a current MARKSANS.NS stock price?
Marksans Pharma Limited MARKSANS.NS stock price today per share is 157.2 INR.
How to purchase Marksans Pharma Limited stock?
You can buy MARKSANS.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Marksans Pharma Limited?
The stock symbol or ticker of Marksans Pharma Limited is MARKSANS.NS.
Which industry does the Marksans Pharma Limited company belong to?
The Marksans Pharma Limited industry is Drug Manufacturers-General.
How many shares does Marksans Pharma Limited have in circulation?
The max supply of Marksans Pharma Limited shares is 446.69M.
What is Marksans Pharma Limited Price to Earnings Ratio (PE Ratio)?
Marksans Pharma Limited PE Ratio is 22.23479500 now.
What was Marksans Pharma Limited earnings per share over the trailing 12 months (TTM)?
Marksans Pharma Limited EPS is 7.07 INR over the trailing 12 months.
Which sector does the Marksans Pharma Limited company belong to?
The Marksans Pharma Limited sector is Healthcare.